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ABSTRACT  
Objective: Derivative, ratio spectra derivative and ratio difference spectrophotometric methods were developed and validated for simultaneous 
determination of Nicardipine (NIC) in the presence of its alkaline induced degradation products.  
Methods: In these methods the overlapped spectra of NIC and its alkaline induced degradation products were well resolved by measuring the 
amplitudes of first derivative (DP1P) spectra and the second derivative (DP2P) at 382.3 and 239 nm, respectively. NIC was determined by ratio spectra 
derivative by measuring the amplitude at 244 nm. The ratio difference spectrophotometric method was developed in which the difference between 
amplitudes at 237.5 nm and 260 nm of the ratio spectra were recorded. The linearity range for the applied methods was 2-18 μg/ml.  
Results: All the developed methods were validated according to ICH Guidelines, NIC was determined with acceptable accuracy and precision.  
Conclusion: These methods were suitable as stability indicating methods for the determination of NIC in the presence of its alkaline induced 
degradation products either in bulk powder or in a pharmaceutical formulation. Statistical analysis of the results with those obtained by applying a 
reported method has been carried out revealing high accuracy and good precision.  
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INTRODUCTION  
Nicardipine hydrochloride (NIC) was designated as 2-[Benzyl (methyl) 
amino] ethyl methyl 1, 4-dihydro-2, 6-dimethyl-4-(3-nitrophenyl) 
pyridine-3, 5-dicarboxylate hydrochloride [1]. It is a calcium channel 
antagonist of dihydropyridine class. It is currently used for the 
management of angina pectoris and also used in the treatment of 
hypertension [2].  
Few methods have been reported for determination of NIC: these 
methods included spectrophotometry [3-6], voltammetry [7], high-
performance liquid chromatography [8-10], liquid chromatography–
mass spectrometry [11-13], and capillary electrophoresis [14]. A 
study on forced degradation and degradation kinetics was also 
reported [15, 16]. Most of the previously reported work was focused 
on the determination of NIC in biological fluids.  
Thus, our aim was to develop and validate simple spectro-
photometric stability indicating methods for the determination of 
NIC in the presence of its alkaline induced degradation products. 
These methods include first derivative, second derivative, derivative 
ratio and ratio difference. 
Experimental 
Instruments 
Spectrophotometer, UV–VIS Spectrophotometer (1650 Shimadzu, 
kyoto, Japan) with UV-PC personal spectroscopy software version 
3.7 (Shimadzu) with quartz cells of 1 cm path length. The spectral 
bandwidth was 2 nm and the wavelength scanning speed was 2800 
nm/min. IR Spectrometer, Shimadzu 435 (Kyoto, Japan), sampling 
was prepared in disc form with potassium bromide. Mass spectro-
photometer, MS-QB 1000 EX, Finnigan Nat (USA). 
Chemicals and reagents 
Pure NIC, batch no. C 100921585, its purity was found to be 100.23% 
according to the reported method [6] was purchased from (SIGMA 
Aldrich, USA). LoxenP®P tablets, batch no. T0109, were manufactured by 
Novartis pharm S. A. S. France and purchased from international market 
(France). Methanol used was of HPLC grade (SIGMA Aldrich, USA). Other 
chemicals were of analytical grade. Chloroform and hydrochloric acid 
(Al-Gomhoria, Egypt), Sodium hydroxide (Adwic, Egypt) 
Solutions 
Standard solution 
A standard stock solution of NIC (0.1 mg/ml) was prepared by 
dissolving accurately weighed 10 mg of NIC in 100-ml volumetric 
flask using methanol as solvent.  
Preparation and identification of degradation products  
Preparation of alkaline induced degradation products was 
performed by transferring accurately weighed 50 mg of pure NIC in 
a standard 250-ml conical flask, these dissolving in 50-ml methanol, 
50-ml of 0.5N NaOH were added, and the solution was left for 7 h in 
an oven at 100°C. The solution was allowed to cool at room 
temperature then neutralized by 0.5N hydrochloric acid, evaporated 
under vacuum nearly to dryness, transferred, dissolved and 
completed to volume with methanol in 50-ml volumetric flask. For 
the purpose of identification, the solution was spotted on to 
preparative TLC-plates, developed using chloroform: methanol (9:1, 
v/v). Two bands were separated, scratched, dissolved in methanol, 
filtered, evaporated to dryness and the dried powder of each of the 
two degradation products were subjected to MS and IR analysis.  
Spectrophotometric methods 
Spectral characteristics 
The absorption spectra of standard solution NIC and its degradation 
products were recorded over the range 200-400 nm using methanol 
as blank.  
Construction of calibration curves  
Aliquots of NIC standard solution were accurately transferred into a 
set of 10-ml volumetric flask and the volume was completed with 
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methanol to reach a final concentration range of (2.00-18.00 µg/ml). 
The absorption spectra of the resulting solution were measured in 





Second derivative (DP2P) method 
DP2Pcurves of the stored spectra were calculated using (∆λ=4.00, 
scale=100), the peaks amplitude at 239 nm were plotted versus the 
corresponding concentrations, and the regression equation was 
computed. 
Derivative ratio method (DDP1 P) 
The stored spectra were divided by the absorption spectrum of 4.00 
µg/ml of NIC degradation products; the obtained ratio spectra were 
subjected to DP1P calculation using (∆λ=4.00, scale=10). The peak 
amplitudes at 244 nm were plotted versus the corresponding 
concentration, and a regression equation was computed.  
Ratio difference method (RD) 
The stored spectra were divided by the absorption spectrum of 4.00 
µg/ml of NIC degradation products. The differences between the 
amplitude at 237.4 nm and 260 nm of the obtained ratio spectra 
were calculated, plotted versus the corresponding concentration of 
NIC, and the regression equation was computed. 
Assay of laboratory prepared mixtures 
Different mixtures of NIC and NIC degradation products were 
prepared by accurately transferring aliquots from their solutions to 
prepare mixtures containing from 10%-80% of NIC degradation 
products. Then the procedure under each method was followed.  
Assay of pharmaceutical formulations  
10 tablets of LoxenP®P tablets were weighed and finely powdered. 
Accurately weighed the amount of the powder, equivalent to 0.01g of 
NIC, was transferred into 100-ml volumetric flask , mechanically 
shaken for 20 min, filtered, and the volume was completed to obtain 
0.1 mg/ml solution. The absorption spectra of the resulting solution 
were measured in the range of 200-400 nm and the procedure of each 
method was followed. The concentration of NIC was calculated by each 
of the proposed methods from its corresponding regression equation.  
RESULTS AND DISCUSSION 
The International Conference on Harmonization (ICH) guideline 
entitled "stability testing of new drug substances and products" 
required the stress testing to be carried to elucidate the inherent 
stability characteristics of the active substance. An ideal stability 
indicating method is the one that quantifies the standard drug alone 
and also resolved its degradation products [17]. 
The two ester groups attached to dihydropyridine ring in NIC have 
hydrolysed in alkaline medium resulted in the formation of two 
degradation products and methanol. The alkaline hydrolysis was 
achieved by heating NIC with 0.5 N NaOH at 60 °C for one hour [16].  
Many trials were achieved for choice the condition of degradation of 
NIC, but the best results for complete degradation were achieved by 
heating NIC with 1 N NaOH at 100 °C for 7 h.  
The focus of the present work was to develop a simple, accurate, 
specific and reproducible stability indicating spectrophotometric 
methods for the determination of NIC in its pure form and in 
pharmaceutical formulations in the presence of its alkaline induced 
degradation products.  
Complete hydrolysis was achieved upon using 0.5 N NaOH for 7 h at 
100 °C (fig. 1). The drug undergoes complete degradation into two 
degradation products and methanol. 
 
Fig. 1: Proposed scheme for preparing the degradation products 
of NIC 
 
Separation of degradation products was achieved by application to 
preparative TLC plates using chloroform: methanol (9:1, v/v) as a 
developing solvent. 
The separated degradation products were studied using MS and IR 
analyzes.  
MS–analysis reveals parent peaks at 166.71 and 226.43 m/z, 
corresponding to the molecular weights of the two degradation 
products (fig. 2). By the comparison of the these IR-spectra of NIC 
with that the degradation products, the characteristic band at 1735-
1750 corresponding to the C=O of the ester groups shown in (fig. 3), 
has been disappeared in the IR-spectra of degradation products (fig. 
4 A, B) with the appearance of two new peaks at 3400, 1700 
corresponding to hydroxyl and carboxylic groups, respectively.  
 
 
Fig. 2: Mass chart of the degradation products of NIC 
 
 
Fig. 3; IR chart of NIC 
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 curves of the stored spectra were calculated using (∆λ=4.00, 
scale=100), the peaks amplitude at 382 nm were plotted versus the 






Fig. 4(A, B): IR chart of degradation products 
 
NIC and its degradation products spectra (fig. 5), showed spectral 
overlapped with the degradation products at wavelength 350 nm 
and 250 nm.  
 
 
Fig. 5: Zero order absorption spectra of (10.00 µg/ml) of NIC (—) 
and (10.00 µg/ml) of the alkaline degradation products (----) 
using methanol as blank 
 
First derivative method 
In order to optimize D1method, different smoothing and scaling 
factors were tested, where a smoothing factor ∆λ= 4.00 and a 
scaling factor = 100 showed a suitable signal to noise ratio and the 
spectra showed good resolution. D1 
 
method was based on 
measuring the peak amplitude of NIC at 382 nm (fig. 6), 
(corresponding to zero-crossing of the degradation products). This 
method gave satisfactory results for NIC in the presence of up to 
30% of its degradation products.  
 
Fig. 6: First derivative spectra of 10.00 µg/ml of each of NIC (-) 
and degradation products (----) using methanol as blank 
 
Second derivative method (D2
In order to optimize D
)  
2 method, different smoothing and scaling 
factors were tested, where a smoothing factor ∆λ= 4.00 and a 
scaling factor = 100 showed a suitable signal to noise ratio and the 
spectra showed good resolution. The peak amplitudes of D2
 
 
spectrum of NIC at 239 nm (fig. 7), (corresponding to zero-
crossing of the degradation products) was measured. This method 
could determine NIC in the presence of up to 80% of its 
degradation products. 
 
Fig. 7: Second derivative spectra of 10µg/ml of each of NIC (-) 
and the degradation products (----) in methanol 
 
First derivative of ratio spectra (DD1
In order to improve the selectivity of the analysis of NIC in the 
presence of alkaline induced degradation products, DD
) method  
1 
spectrophotometric method was developed. The main advantage of 
the method is that the whole spectrum of the interfering substance 
was canceled. Accordingly, the choice of the wavelength for 
calibration was not critical as in derivative methods. In order to 
optimize DD1 method, several divisors concentrations (2.00-16.00 
µg/ml) were tried, the best result was obtained upon using 4.00 
µg/ml of the degradation products. Different smoothing and scaling 
factors were tested, where a smoothing factor ∆λ = 4.00 and a 
scaling factor = 10 were suitable to enlarge the signal of NIC to 
facilitate its measurement and to diminish the error (fig. 8,9). DD1 
values showed good linearity and reproducibility at 244 nm.  
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Fig. 8: Ratio spectra of NIC 6-18µg/ml (—) using 4 µg/ml of 
degradation products as a divisor 
 
.  
Fig. 9: First derivative of ratio spectra of NIC (2.00–18.00 µg/ml) 
using 4 µg/ml of Degradation alkaline products as a divisor 
 
Ratio difference method (RD) 
The amplitude difference between two points on the ratio spectra of 
a mixture is directly proportional to the concentration of the 
component of interest; independence of the interfering component 
was the basic principle of the difference ratio method [18].  
The spectra of NIC were scanned. The laboratory prepared mixtures 
were measured and divided by the absorption spectra of 4.00µg/ml 
alkaline induced degradation products, where they obtained ratio 
spectra were recorded. The calibration curve for NIC was 
constructed by plotting the difference between the amplitudes of 
obtained ratio spectra at 237.4 nm and 260 nm versus the 
corresponding concentrations of NIC.  
Method validation 
Method validation was performed according to ICH guidelines for 
the proposed methods as follows:  
Range and linearity 
The linearity of the method was evaluated by processing 6 points 
calibration curve on 3 different days. A linear relationship was 
obtained in the range of 2.00-18.00 µg/ml. A linear least-square 
regression analysis was conducted to determine slope, intercept, 
and coefficient of determination to demonstrate linearity of the 
method. The linear regression analysis data are summarized in 
table 1. 
Limits of detection and quantitation 
The limit of detection (LOD) and limit of quantification (LOQ) was 
calculated as the ratio of 3.3 and 10 standard deviations of 
regression residuals, respectively, and the slope.  
Accuracy 
The procedure under the study of linearity was repeated three 
times for determination of six different concentrations of pure 
NIC. The accuracy expressed as percentage recoveries were 
shown in table 1.  
Precision 
The precision was determined by analysis of 3 different 
concentrations of pure NIC (6.00, 8.00, 10.00 µg/ml) within the 
linearity range for NIC. Both intraday precision and inter-day precision 
were determined. The results are presented as RSD% in table 1. 
The proposed methods successfully used for the determination of 
NIC in laboratory prepared mixtures containing different ratios of 
the drug and its degradation products. The mean recovery 
percentages and standard deviations were illustrated in table 2. 
The suggested methods were successfully applied for the analysis of 
NIC in a pharmaceutical formulation. The accuracy of the method 
was further assessed by applying the standard addition technique; 
good results were obtained and shown in table 3. 
The results obtained by applying the proposed methods were 
compared to those obtained by apply the reported HPLC method [6], 
no significant difference was found with respect to both accuracy 
and precision as shown in table 4. 
 
Table 1: Assay parameters and validation sheet for determination of NIC by the proposed method 
 RD *  DDP1P method*  DP2P method*  DP1P method* Parameters 
2.00-18.00  2.00-18.00  2.00-18.00  2.00-18.00  Range (µg/ml) 
0.02 0. 21 0.04 0.02 Slope 
0.02 0.02 0.03 0.03 Intercept 











1.04 0.99 1.47 1.28 RSD%PaP* 
0.98 1.13 0.80 0. 84 RSD% PbP* 
0.14 0.27 0.24 0.21 LOD (µg/ml) 
0.43 0.84 0.74 0.65 LOQ (µg/ml) 
RSD %PaP* Interday and RSD% Pb P*Intraday of samples of concentrations (6, 8, 10 µg/. ml) for DP1P, DP2P, DDP1P, and RDSM method, *DP1P: First derivative 
method, *DP2P: Second derivative method, *DDP1P: Derivative ratio method, *RD: Ratio difference spectrophotometric method, The sample sizes are 
three separate determinations. 
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Table 2: Determination of NIC in laboratory prepared mixtures by the proposed spectrophotometric methods 
Mixture No. % of degradation products DP1 P method DP2 P method DDP1 P method RD 
1 10 101.20 99.02 100.86 99.84 
2 20 101.27 99.71 100.85 100.11 
3 30 101.65 101.96 98.48 98.55 
4 40  100.48 100.69 99.85 
5 50  100.22 101.09 100.71 
6 60  100.33 98.99 98.96 
7 70  101.50 101.28 100.72 
8 80  100.00 98.22 102.02 
 Mean±SD  101.38±0.23 100.41±0.94 100.06±1.27  100.10±1.08 
 
Table 3: Determination of NIC in Loxen® tablet by proposed methods and application of standard addition technique 
RD DDP1 P method DP2 P method DP1 P method 







98.46 99.34±1.64 Loxen® tablet labeled to 
contain 20 mg/tab. 
B. No. T0109 
101.79 100.88 99.38 99.82 











Table 4: Statistical comparison of the results obtained by the proposed methods and the reported method for determination of NIC 
hydrochloride 
Reported methodP(4)P* Spectrophotometric method Values 
 RD DDP1 DP2 DP1  
100.24 99.81 98.98 100.04 100.16 Mean percentage recovery 
1.26 1.77 1.42 0.99 1.24 SD 
1.59 3.13 2.02 0.98 1.54 variance 
5.00 7.00 7.00 7.00 7.00 n 














The developed methods are simple, sensitive and rapid stability 
indicating ones for determination of NIC in pure form, in pharmaceutical 
formulations and in the presence of its alkaline induced degradation 
products. The RD method advantage over the derivative method that the 
signal to noise ratio is enhanced. These methods were simple, more 
convenient, less time consuming and economic stability indicating 
methods compared to chromatographic methods. 
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